Live Breaking News & Updates on Anat Cohen Dayag

Stay updated with breaking news from Anat cohen dayag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Israel General , Tel Aviv , San Francisco , United States , Daiichi Sankyo , Yvonne Naughton , Exchange Commission , Corporate Communications , Stock Exchange , Securities Exchange , Compugen Ltd , Anat Cohen Dayag , Chief Executive Officer , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Investor Relations ,

Compugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen s First Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Yvonne Naughton , Asthika Goonewardene , Alberto Sessa , Daiichi Sankyo , Tony Butler , Michelle Mahler , Rodman Renshaw , David Silberman , Daina Graybosch , Stephen Willey , Compugen Ltd , Corporate Communications , Call Transcript May , First Quarter , Investor Relations , Anat Cohen Dayag , Chief Executive Officer , Chief Financial , Chief Medical Officer , Eran Ophir , Chief Scientific Officer , Keystone Symposium , American Association , Cancer Research Conference , Chief Financial Officer ,

Compugen Reports First Quarter 2024 Results

Compugen Reports First Quarter 2024 Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Israel General , San Francisco , United States , Tel Aviv , Yvonne Naughton , Stock Exchange , Securities Exchange , Exchange Commission , Compugen Ltd , Corporate Communications , Anat Cohen Dayag , Chief Executive Officer , Leerink Partners , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Investor Relations ,

Compugen : Reports First Quarter 2024 Results

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF. ....

San Francisco , United States , Israel General , Tel Aviv , Yvonne Naughton , Corporate Communications , Commission File Number , Tel Aviv Stock Exchange , Compugen Ltd , Company Registration Statement On Form , Securities Exchange , Exchange Commission , File Number , Principal Executive Offices , Anat Cohen Dayag , Press Release , Registration Statement , Reports First Quarter , Securities Exchange Act , Eran Ben Dor , Chief Executive Officer , Leerink Partners , Webcast Information , Securities Act , Private Securities Litigation Reform Act , Annual Report ,

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

/PRNewswire/ Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today. ....

United States , San Diego , Tel Aviv , San Francisco , Yvonne Naughton , Exchange Commission , Compugen Ltd , Gilead Sciences , Tel Aviv Stock Exchange , Cancer Immunology Research , Corporate Communications , Securities Exchange , American Association For Cancer Research , American Association , Cancer Research , Anat Cohen Dayag , Chief Executive Officer , Chief Scientific Officer , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Middle East , Annual Report , Investor Relations , Compugen Ltd , Health Care Amp Hospitals ,